Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-1040b and clopidogrel drug interaction in healthy subjects
NCT02560688Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of DS1040b in thromboembolic disease, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Number of adverse events at 5 days, Physical exam profile at 5 days and 1 more. Started Dec 2015; status: completed.
02
Drugs
DS1040b
03
Conditions
thromboembolic disease
Beyond the preview
Go deeper on NCT02560688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560688.